{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:19:02Z","timestamp":1756462742022,"version":"3.37.3"},"reference-count":30,"publisher":"Wiley","issue":"2-3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2406,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1600-0404.1996.tb00181.x","type":"journal-article","created":{"date-parts":[[2010,7,24]],"date-time":"2010-07-24T20:25:02Z","timestamp":1280003102000},"page":"94-98","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacokinetics of dextromethorphan and dextrorphan in epileptic patients"],"prefix":"10.1155","volume":"93","author":[{"given":"A.","family":"Kazis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Kimiskidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Niopas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0006-8993(90)90838-3","article-title":"Effects of non-opioid antitussives on epileptiform activity and NMDA responses in hippocampal and olfactory cortex slices","volume":"529","author":"Apland","year":"1990","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0304-3940(88)90362-X","article-title":"Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N-methyl-D-aspartate in brain slices","volume":"85","author":"Wong","year":"1988","journal-title":"Neurosci Lett"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0006-8993(88)91497-7","article-title":"Dextromethorphan and dextrorphan as calcium channel antagonists","volume":"439","author":"Carpenter","year":"1988","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(93)90849-D","article-title":"Dextromethorphan blocks N-methyl-D- aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons","volume":"238","author":"Netzer","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0165-6147(89)90050-3","article-title":"Dextromethorphan and neuromodulation: old drug coughs up new activities","volume":"10","author":"Tortella","year":"1989","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.40.3_Part_1.547","article-title":"Dextromethorphan for treatment of complex partial seizures","volume":"40","author":"Fisher","year":"1990","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/j.1552-4604.1987.tb02174.x","article-title":"The polymorphic metabolism of dextromethorphan","volume":"27","author":"Woodworth","year":"1987","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00007691-199001000-00018","article-title":"Simultaneous determination of dextromethorphan and three metabolites in plasma and urine using high performance liquid chromatography with application to their disposition in man","volume":"12","author":"Chen","year":"1990","journal-title":"Ther Drug Monit"},{"volume-title":"Concepts and Applications","year":"1989","author":"Rowland","key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB9|cit9"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB10|cit10","first-page":"149","article-title":"Dextromethorphan population kinetics","volume":"45","author":"Miller","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0041-008X(80)90218-5","article-title":"Urinary excretion of dextromethorphan and three metabolites in dogs and humans","volume":"55","author":"Barnhart","year":"1980","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0378-5173(83)90092-3","article-title":"Inter-individual variation in the metabolism of dextromethorphan","volume":"14","author":"Pfaff","year":"1983","journal-title":"Int J Pharmac"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB13|cit13","first-page":"493","article-title":"Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers","volume":"25","author":"Silvasti","year":"1987","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2125.1989.tb05354.x","article-title":"Dextromethorphan: polymorphic serum pattern of the o-demethylated and didemethylated metabolites in man","volume":"27","author":"Mortimer","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0003-2697(87)90006-6","article-title":"High performance liquid chromatographic assays for bufuralol 1\u2032-hydroxylase, debrisoquine 4-hydroxylase and dextromethorphan o-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver","volume":"162","author":"Kronbach","year":"1987","journal-title":"Analytical Biochem"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jmg.17.2.102","article-title":"A family and population study of the genetic polymorphism of debrisoquine oxidation in a white European population","volume":"17","author":"Evans Dap","year":"1980","journal-title":"J Med Genet"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0888-7543(88)90100-0","article-title":"Human debrisoquine 4-hydroxylation (P450 IIDI):cDNA and deduced amino acid sequence and assignment of the CYP2D6 locus to chromosome 22","volume":"2","author":"Gonzalez","year":"1988","journal-title":"Genomics"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0006-2952(90)90283-Q","article-title":"Inhibitory studies of mexiletine and dextromethorphan oxidation in human liver microsomes","volume":"39","author":"Broly","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB19|cit19","first-page":"491","volume-title":"Antiepileptic Drugs.","author":"Faigle","year":"1989"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/01616412.1993.11740131","article-title":"Neuroprotection following focal cerebral ischemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile","volume":"15","author":"Steinberg","year":"1993","journal-title":"Neurol Res"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/clpt.1992.77","article-title":"Dextromethorphan: enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome 4502D6","volume":"51","author":"Zhang","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/clpt.1993.43","article-title":"Inhibition by fluoxetine of cytochrome P450 2D6 activity","volume":"53","author":"Otton","year":"1993","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1528-1157.1993.tb02425.x","article-title":"Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats","volume":"34","author":"Prendiville","year":"1993","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0022-3565(25)23652-7","article-title":"Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands","volume":"248","author":"Aram","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB25|cit25","first-page":"141","article-title":"Clinical dose-escalation safety study of the NMDA antagonist dextromethorphan in neurosurgical patients","volume":"22","author":"Steinberg","year":"1991","journal-title":"Stroke"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0014-2999(92)90866-3","article-title":"Kindled rats are more sensitive than non-kindled rats to the behavioural effects of combined treatment with MK-801 and valproate","volume":"22","author":"Dziki","year":"1992","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 5","key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1111\/j.1528-1157.1994.tb05972.x","article-title":"Dextromethorphan: cellular effects reducing neuronal hyperexcitability","volume":"35","author":"Trube","year":"1994","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/jcbfm.1991.169","article-title":"Protection after transient focal cerebral ischemia by the N-methyl-D-Aspartate antagonist is dependent upon plasma and brain levels","volume":"11","author":"Steinberg","year":"1991","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Suppl","key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB29|cit29","first-page":"S193","article-title":"Dextromethorphan\/dextrorphan disposition in rat plasma and brain","volume":"5","author":"Wills","year":"1988","journal-title":"Pharm Res"},{"key":"10.1111\/j.1600-0404.1996.tb00181.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00008571-199308000-00004","article-title":"CYP2D6- and CYP3A4-dependent metabolism of dextromethorphan in humans","volume":"3","author":"Jacqz-Airgrain","year":"1993","journal-title":"Pharmacogenetics"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.1996.tb00181.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.1996.tb00181.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T09:47:28Z","timestamp":1740304048000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.1996.tb00181.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,29]]},"references-count":30,"journal-issue":{"issue":"2-3"},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.1996.tb00181.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"type":"print","value":"0001-6314"},{"type":"electronic","value":"1600-0404"}],"subject":[],"published":{"date-parts":[[2009,1,29]]}}}